AI Proteins is re-imagining the possibilities of protein therapeutics by rationally designing entirely new proteins to carry out specific therapeutic functions. Using AI-based design and a high-throughput drug discovery platform, AI proteins creates synthetic proteins from scratch and optimizes a proteins activity for each therapeutic application. This engineering process enables the development of proteins that are inexpensive, durable, highly specific, and can be optimized for oral delivery.
Privately Funded Company
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):